bibliographic entry 1463614 [be/1463614]
https://w3id.org/oc/corpus/be/1463614

is a
content
  • Kreitman, R.J, Tallman, M.S, Robak, T, Coutre, S, Wilson, W.H, Stetler-Stevenson, M, Fitzgerald, D.J, Lechleider, R, Pastan, I. Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia, J. Clin. Oncol, 2012, 30, 1822, 1828, DOI: 10.1200/JCO.2011.38.1756, PMID: 22355053
references